Leukemia: Clinical Trials

15 trials for Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 terminated. 15 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 415Terminated 15

Follow Leukemia: new trials by email Literature Review of Leukemia trials Research Report on Leukemia

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase
Levofloxacin, Placebo - Neutropenic Fever, Acute Lymphoblastic Leukemia
Phase 4TerminatedGadjah Mada University492026-01-012026-10-01
Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL
Flumatinib, Imatinib - Acute Leukemia
Phase 4TerminatedInstitute of Hematology & Blood Diseases Hospital, China392021-09-162025-05-01
Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)
Blinatumomab, Current Wearable Heatlth Monitoring System (CWHMS) - B-precursor Acute Lymphoblastic Leukemia
Phase 4TerminatedAmgen102021-08-262025-05-18
N-Acetylcysteine vs Placebo as Adjunctive Treatment in Pediatric Leukemia
N-Acetylcysteine, Placebo - Lymphoblastic Leukemia, Acute, Childhood
Phase 4TerminatedTeny Tjitra Sari162019-08-292022-11-09
Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia
Outpatient Care Model, CPX-351 - Leukemia, Myeloid, Acute
Phase 4TerminatedMedical College of Wisconsin32019-08-282022-07-19
Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients
Ketamine 100 MG/ML, Midazolam 5 MG/ML - Anxiety, Pediatric ALL
Phase 4TerminatedBrooke Army Medical Center102016-05-012023-04-25
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
Bosutinib - Previously Treated PH + CML
Phase 4TerminatedPfizer1632014-11-072021-12-30
A Study to Evaluate Efficacy and Safety of Glinib in Newly Diagnosed CML Patients
600mg/day of Imatinib, 400mg/day of Imatinib - Chronic Myeloid Leukemia
Phase 4TerminatedDong-A ST Co., Ltd.552014-10-132018-06-15
Efficacy and Safety Assessment of NIlotinib in CML Patients With Suboptimal Response on Imatinib Therapy
Nilotinib 300 mg. - Myeloid Leukemia, Chronic
Phase 4TerminatedKing Abdullah International Medical Research Center982013-03-012017-03-07
A Study of Rituximab in Combination With Fludarabine and Cyclophosphamide in Participants With Chronic Lymphocytic Leukemia and Favorable Somatic Status
Cyclophosphamide, Fludarabine, Rituximab - Lymphocytic Leukemia, Chronic
Phase 4TerminatedHoffmann-La Roche892011-06-172018-03-20
A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Participants With Chronic Lymphocytic Leukemia and Unfavorable Somatic Status
Chlorambucil, Cyclophosphamide, Fludarabine - Lymphocytic Leukemia, Chronic
Phase 4TerminatedHoffmann-La Roche262011-04-272019-03-14
SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological Patients
filgrastim - Leukemia
Phase 4TerminatedRabin Medical Center1202011-01-012016-04-06
Study of Nilotinib in Ph+ CML-CP Patients With Low Imatinib Trough Plasma Concentrations
nilotinib - CML, Philadelphia Chromosome Positive (Ph+)
Phase 4TerminatedNovartis Pharmaceuticals32010-10-212021-05-20
Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma
PEG-interferon alfa-2b, Interferon alfa-2b, Valproic Acid - Lymphoma, Precancerous/Nonmalignant Condition
Phase 4TerminatedUniversity of Miami132007-11-012018-04-17
Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib
bone marrow aspiration - Chronic Myeloid Leukemia, Gastrointestinal Stromal Cell Tumors
Phase 4TerminatedUniversity Health Network, Toronto682005-02-012009-02-13

Narrower conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma (5)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (4)  ·  Febrile Neutropenia (2)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Anxiety Disorders (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Chromosome Aberrations (1)  ·  HTLV-I Infections (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myeloid, Chronic-Phase (1)  ·  Lymphoma (1)  ·  Neoplasm, Residual (1)  ·  Precancerous Conditions (1)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Hematologic Diseases (15)  ·  Hemic and Lymphatic Diseases (15)  ·  Neoplasms (15)  ·  Neoplasms by Histologic Type (15)  ·  Immune System Diseases (9)  ·  Immunoproliferative Disorders (8)  ·  Leukemia, Lymphoid (8)  ·  Lymphatic Diseases (8)  ·  Lymphoproliferative Disorders (8)  ·  Pathologic Processes (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Chronic Disease (7)  ·  Disease Attributes (7)  ·  Leukemia, Myeloid (6)

Interventions

Cyclophosphamide (2)  ·  Imatinib Mesylate (2)  ·  Rituximab (2)  ·  fludarabine (2)  ·  nilotinib (2)  ·  Acetylcysteine (1)  ·  CPX-351 (1)  ·  Chlorambucil (1)  ·  Cytarabine (1)  ·  Filgrastim (1)  ·  Interferon alpha-2 (1)  ·  Ketamine (1)  ·  Levofloxacin (1)  ·  Midazolam (1)  ·  Valproic Acid (1)

Sponsors

Hoffmann-La Roche (2)  ·  Amgen (1)  ·  Brooke Army Medical Center (1)  ·  Dong-A ST Co., Ltd. (1)  ·  Gadjah Mada University (1)  ·  Institute of Hematology & Blood Diseases Hospital, China (1)  ·  King Abdullah International Medical Research Center (1)  ·  Medical College of Wisconsin (1)  ·  Novartis Pharmaceuticals (1)  ·  Pfizer (1)  ·  Rabin Medical Center (1)  ·  Teny Tjitra Sari (1)  ·  University Health Network, Toronto (1)  ·  University of Miami (1)

Countries

United States (6)  ·  Indonesia (2)  ·  Russia (2)  ·  Austria (1)  ·  Canada (1)  ·  China (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Norway (1)  ·  Saudi Arabia (1)  ·  South Korea (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Chul-won Choi, M.D. (1)  ·  Chul-won Jung, M.D. (1)  ·  Dr. Ahmad S. Alaskar, MD,FACP,FRCP (1)  ·  Duk-yeon Cho, M.D. (1)  ·  Idha Yulandari, M.D. Pediatric (1)  ·  Jeff Lipton, MD (1)  ·  Jin-hee Park, M.D. (1)  ·  Joo-sup Joeng, M.D. (1)  ·  Joon-sung Park, M.D. (1)  ·  Juan Carlos Ramos, MD (1)  ·  Jung-ok Lee, M.D. (1)  ·  Kyu-Hyoung Lee, M.D. (1)  ·  Kyung-ha Kim, M.D. (1)  ·  Laura Michaelis, MD (1)

Results publications

PMID 30208456, PMID 32572189, PMID 33041718, PMID 35235189, PMID 38007586, PMID 38484432, PMID 39164407

NIH funding

P01CA128115 (1)